100 Years of Alzheimer's disease (1906-2006)

Journal of Alzheimer's Disease

Volumn 9, Issue SUPPL. 3, 2006, Pages 15-26

  Lage, José Manuel Martínez ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b 2AB ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; CHOLINE; CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE; FLUORODEOXYGLUCOSE; GALANTAMINE; LEVODOPA; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHOSPHATIDYLCHOLINE; RIVASTIGMINE; SCOPOLAMINE; TACRINE; TAU PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; AUTOPSY; BRAIN; BRAIN DISEASE; CAREER; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; ELECTRON MICROSCOPY; FAMILIAL DISEASE; GENE MUTATION; HISTORY OF MEDICINE; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MOUSE; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHIATRIST; PUBLICATION; REVIEW; SENILITY; TRANSGENIC MOUSE;

EID: 33747404581     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2006-9s303     Document Type: Review

References (35)

1. A. Alzheimer, Über einen eigenartigc Erkrankung der Hirnrinde, Allgemeine Zeitschrift für Psyciatrie und Psychisch-Gerichtliche Medizin 64 (1907), 146-148.
2. J.F. Ballenger, Beyond the characteristic plaques and tangles. Mid-twentieth century US Psychiatry and the fight against senility, in: Concepts of Alzheimer's Disease, Biological, clinical, and cultural perspectives, P.J. Whitehouse, K. Maurer and M.A. Ballenger, eds, Baltimore, Johns Hopkins University Press, 2000, 83-83-103.
3. G.E. Berrios, Dementia: historical overview, in: Dementia, (Second edition), J. O'Brien, D. Ames and A. Burns, eds, London, Arnold, 2000, pp. 3-13.
4. K. Bick, Interview with Robert Katzman, in: Alzheimer disease, The changing view, R. Katzman and K. Bick, eds, San Diego, Academic Press, 2000, pp. 252-271.
5. K.L. Bick, The early story of Alzheimer disease, in: Alzheimer Disease, R.D. Terry, R. Katzman and K.L. Bick, eds, New York, Raven Press, 1994, pp. 1-8.
6. G. Blessed, B.E. Tomlinson and M. Roth, The association between quantitative measures of dementia and of senile changes in the cerebral matter of elderly subjects, Br J Psychiat 114 (1968), 797-811.
7. H. Braak and E. Braak, Neurofibrillary changes. The hallmark of Alzheimer disease, in: Concepts of Alzheimer's Disease, Biological, clinical, and cultural perspectives, P.J. Whitehouse, K. Maurer and M.A. Ballenger, eds, Baltimore, Johns Hopkins, 2000, pp. 53-77.
8. E. Bufill and R. Blesa, Alzheimer's diseqase and brain evolution: Is Alzheimjer's disease an example of antagonistic pleiotropiy? Rev Neurol 42 (2006), 25-33.
9. M.B. Graeber, S. Kösel, E. Grasbon-Frodl, H. Möller and P. Mehraein, Histopathology and APOE genotype of the first Alzheimer's disease patient Auguste D, Neurogenetics 1 (1998), 223-228.
10. R. Katzman and K. Bick, Alzheimer Disease, The changing view. San Diego, Academic Press, 2000, 387.
11. R. Katzman and K. Bick, Cognitive decline in the elderly and AD pathology - The first prospective study: Newcastle, in: Alzheimer disease, The changing view, R. Katzman and K. Bick, eds, San Diego, Academic Press, 2000, pp. 46-66.
12. R. Katzman and K. Bick, Experimental models. Henry Wisniewski, in: Alzheimer Disease, R. Katzman and K. Bick, eds, San Diego, Academic Press, 2000, pp. 11-28.
13. R. Katzman and K. Bick, Mikel Kidd, in: Alzheimer Disease, The changing view, R. Katzman and K. Bick, eds, San Diego, Academic Press, 2000, pp. 28-46.
14. R. Katzman and K. Bick, The cholinergic story: Hope for the patient and family, in: Alzheimer Disease, The changing view, R. Katzman and K. Bick, eds, San Diego, Academic Press 2000, pp. 167-210.
15. R. Katzman and K. Bick, The next act, in: Alzheimer Disease, The changing view, R. Katzman and K. Bick, eds, San Diego, Academic Press, 2000, pp. 353-378.
16. R. Katzman and K. Bick, The rediscovery of Alzheimer disease during the 1960s and 1970s, in: Concepts of Alzheimer's Disease, Biological, clinical, and cultural perspectives, P.J. Whitehouse, K. Maurer and M.A. Ballenger, eds, Baltimore, Johns Hopkins University Press, 2000, pp. 104-114.
17. R. Katzman and K. Bick, The rise of the Alzheimer's Association, in: Alzheimer Disease, The changing view, R. Katzman and K. Bick, eds, San Diego, Academic Press, 2000, pp. 312-351.
18. R. Katzman and K. Bick, The ultrastructure of AD. Robert Terry, in: Alzheimer Disease, The changing view, R. Katzman and K. Bick, eds, San Diego, Academic Press, 2000, pp. 11-28.
19. R. Katzman, The prevalence and malignancy of Alzheimer's disease, Arch Neurol 33 (1976), 299-308.
20. E. Kraepelin, Psychiatric: Ein Lehrbuch für Studierende und Ärtze, Leipizg, Barth, 1910, 1129-1136.
21. K. Maurer and U. Maurer, The Life of a Physician and the Career of a Disease, Translated by N Levi with A Burns. New York, Columbia University Pres, 2003, 270.
22. K. Maurer, S. Volk and H. Gerbaldo, Auguste D and Alzheimer's disease, Lancet 349 (1997), 1546-1549.
23. National Institute of Aging, Can Alzheimer's disease be prevented? NIH Publications No. 05-5503, May 2005.
24. National Institute on Aging. Alzheimer's disease Education & Referral Center, Alzheimer's disease Centers Program celebrates 20th anniversary, Connections 12(3-4) (2004-2005), 1-8.
25. B. Reisberg, R. Doody, A. Stoffler, F. Schmitt, S. Ferris and H.J. Mobius, Memantine Study Group. Memantine in moderate-to-severe Alzheimer's disease, N Engl J Med 348(14) (3 Apr. 2003), 1333-1341.
26. L.S. Schneider, Inhibidores de la colinesterasa: presente y futuro, in: En Alzheimer XXI: Ciencia y Sociedad, J.M. Martínez Lage and Z.S. Kachaturian, eds, Barcelona, Masson, 2001, pp. 245-262.
27. D.J. Selkoe, Alzheimer disease: mechanistic understanding predits novel therapies, Ann Intern Med 140 (2004), 627-638.
28. D.J. Selkoe, Alzheimer's disaease: genes, proteins, and therapy, Physiological Reviews 81 (2001), 742-766.
29. D.J. Selkoe, Defining molecular targets to prevent Alzheimer Disease, Arch Neurol 62 (2005), 192-195.
30. W.K. Summers, L.V. Majovski, G.M. Marsh, K. Tachiki and A. Kling, Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type, N Engl J Med 315(20) (13 Nov. 1986), 1241-1245.
31. R.D. Tanzi and A.B. Parson, Decoding Darkness, The search for the genetic causes of Alzheimer's disease. Cambridge, Mass., Perseus, 2000, 281.
32. R.D. Tanzi, Genetics basis of cerebral amyloidosis, Alzheimer & Dementia 1(Supl1) (2005), 1, Abstract AM-01.
33. A. Underwood, 7 Ways to save a Brain, Newswek Special Issue. The future of medicine, Summer 2005, 32.
34. P.J. Whitehouse, D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle and M.R. Delon, Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain, Science 215(4537) (5 Mar 1982), 1237-1239.
35. P.J. Whitehouse, K. Maurer and M.A. Ballenger, eds, Concepts of Alzheimer's Disease, Biological, clinical, and cultural perspectives. Baltimore, Johns Hopkins University Press, 2000, 341.